Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium

BACKGROUND: HIV-associated neurocognitive disorder (HAND) remains highly prevalent despite effective anti-retroviral therapy (ART). A number of adjunctive pharmacotherapies for HAND have been studied with disappointing results, but preliminary data suggest that lithium may provide clinical benefit....

Descripción completa

Detalles Bibliográficos
Autores principales: Decloedt, Eric H., Freeman, Carla, Howells, Fleur, Casson-Crook, Martine, Lesosky, Maia, Koutsilieri, Eleni, Lovestone, Simon, Maartens, Gary, Joska, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120936/
https://www.ncbi.nlm.nih.gov/pubmed/27861379
http://dx.doi.org/10.1097/MD.0000000000005401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120936/
https://www.ncbi.nlm.nih.gov/pubmed/27861379
http://dx.doi.org/10.1097/MD.0000000000005401

Ejemplares similares